UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Platinum resistance in breast and ovarian cancer cell lines

Journal of experimental & clinical cancer research, 2011-10, Vol.30 (1), p.91-91, Article 91

Eckstein, Niels

2011

Volltextzugriff (PDF)

Key results of a series of surveys among German pharmacies, physicians, patients and stakeholders regarding further triptans as potential OTC products

Journal of public health, 2022-02, Vol.30 (2), p.409-415

2022

Volltextzugriff (PDF)

To switch or not to switch—first Germany-wide study from the perspective of pharmacists in the European environment

Journal of public health, 2021-02, Vol.29 (1), p.9-17

2021

Volltextzugriff (PDF)

Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent

Journal of cancer research and clinical oncology, 2021-03, Vol.147 (3), p.779-792

2021

Volltextzugriff (PDF)

Toxicokinetic studies of the four new psychoactive substances 4-chloroethcathinone, N-ethylnorpentylone, N-ethylhexedrone, and 4-fluoro-alpha-pyrrolidinohexiophenone

Forensic toxicology, 2020, Vol.38 (1), p.59-69

2020

Volltextzugriff (PDF)

Characterization and Metabolism of Drug Products Containing the Cocaine-Like New Psychoactive Substances Indatraline and Troparil

Metabolites, 2024-06, Vol.14 (6), p.342

2024

Volltextzugriff (PDF)

Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs

Cancer cell international, 2018-05, Vol.18 (1), p.69-69, Article 69

2018

Volltextzugriff (PDF)

Liquid Chromatography-High-Resolution Mass Spectrometry-Based In Vitro Toxicometabolomics of the Synthetic Cathinones 4-MPD and 4-MEAP in Pooled Human Liver Microsomes

Metabolites, 2020-12, Vol.11 (1), p.3

2020

Volltextzugriff (PDF)

Targeting adipose tissue

Diabetology and metabolic syndrome, 2012-10, Vol.4 (1), p.43-43, Article 43

2012

Volltextzugriff (PDF)

Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective

Journal of experimental & clinical cancer research, 2014-02, Vol.33 (1), p.15-15, Article 15

2014

Volltextzugriff (PDF)

NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells

The Journal of pharmacology and experimental therapeutics, 2010-01, Vol.332 (1), p.238

2010

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Pathway Analysis Identifies Amphiregulin as a Key Factor for Cisplatin Resistance of Human Breast Cancer Cells

The Journal of biological chemistry, 2008-01, Vol.283 (2), p.739-750

2008

Volltextzugriff (PDF)

Y-Box–Binding Protein YB-1 Identifies High-Risk Patients With Primary Breast Cancer Benefiting From Rapidly Cycled Tandem High-Dose Adjuvant Chemotherapy

Journal of clinical oncology, 2009-12, Vol.27 (36), p.6144-6151

2009

Volltextzugriff (PDF)

Allosteric modulation of muscarinic receptor signaling: alcuronium-induced conversion of pilocarpine from an agonist into an antagonist

The Journal of pharmacology and experimental therapeutics, 2002-05, Vol.301 (2), p.720-728

2002

Volltextzugriff (PDF)

Pharmacological characterization of the benz[d]indolo[2,3-g]azecine LE300, a novel type of a nanomolar dopamine receptor antagonist

Naunyn-Schmiedeberg's archives of pharmacology, 2002-12, Vol.366 (6), p.543-550

2002

Volltextzugriff (PDF)

Systemic therapy of Cushing's syndrome

Orphanet journal of rare diseases, 2014-08, Vol.9 (1), p.122-122, Article 122

2014

Volltextzugriff (PDF)

Is sunitinib a Narrow Therapeutic Index Drug? – A systematic review and in vitro toxicology-analysis of Sunitinib vs. Imatinib in cells from different tissues

Regulatory toxicology and pharmacology, 2016-06, Vol.77, p.25-34

2016

Volltextzugriff (PDF)

Resistenzmechanismen von Tumoren gegen Platinkomplexe: Neue Drug Targets und diagnostische Marker

Jahrbuch der Heinrich-Heine-Universität Düsseldorf 2007/2008, 2021, p.249-262

2021

Volltextzugriff (PDF)

NF546 [4,4′-(Carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-α,α′-diphosphonic Acid) Tetrasodium Salt] Is a Non-Nucleotide P2Y 11 Agonist and Stimulates Release of Interleukin-8 from Human Monocyte-Derived Dendritic Cells

The Journal of pharmacology and experimental therapeutics, 2010-01, Vol.332 (1), p.238-247

2010

Volltextzugriff (PDF)

Tyrosine kinase inhibitors becoming generic drugs – risks and chances from a regulatory perspective

GaBI Journal, 2014-06, Vol.3 (2), p.79-87

2014

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Pathway Analysis Identifies Amphiregulin as a Key Factor for Cisplatin Resistance of Human Breast Cancer CellsS

The Journal of biological chemistry, 2007-10, Vol.283 (2), p.739-750

2007

Volltextzugriff (PDF)

The Y-box Binding Protein YB-1 Is Associated with Progressive Disease and Mediates Survival and Drug Resistance in Multiple Myeloma

Blood, 2005-11, Vol.106 (11), p.3385-3385

2005

Volltextzugriff (PDF)

Jahrbuch der Heinrich-Heine-Universitat Dusseldorf 2007/2008

Dusseldorf, Rektor der Heinrich-Heine-Universitat

2008

Volltextzugriff (PDF)

Jahrbuch der Heinrich-Heine-Universität Düsseldorf 2007/2008

Düsseldorf, Rektor der Heinrich-Heine-Universität

2008

Volltextzugriff (PDF)

Der Beitrag der Offizinapotheker zur Optimierung der Arzneimitteltherapiesicherheit - ein Vergleich deutscher, australischer und Schweizer Modelle

Monitor Versorgungsforschung, 2014-02, Vol.7 (1), p.44-51

2014

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

ThemaPhysical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Sprache

Englisch
(31)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(23)
Humans
(13)
Oncology
(9)
Animals
(8)
Medicine
(7)
Medicine & Public Health
(7)
Cell Line, Tumor
(5)
Female
(5)
Apoptosis
(4)
Glioblastoma
(4)
Medical Equipment
(4)
Mice
(4)
Pharmacology & Pharmacy
(4)
Physiological Aspects
(4)
Proteins
(4)
Review
(4)
Antigens
(3)
Antineoplastic Agents - Therapeutic Use
(3)
Biochemistry & Molecular Biology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Platinum resistance in breast and ovarian cancer cell lines

Key results of a series of surveys among German pharmacies, physicians, patients and stakeholders regarding further triptans as potential OTC products

To switch or not to switch—first Germany-wide study from the perspective of pharmacists in the European environment

Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent

Toxicokinetic studies of the four new psychoactive substances 4-chloroethcathinone, N-ethylnorpentylone, N-ethylhexedrone, and 4-fluoro-alpha-pyrrolidinohexiophenone

Characterization and Metabolism of Drug Products Containing the Cocaine-Like New Psychoactive Substances Indatraline and Troparil

Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs

Liquid Chromatography-High-Resolution Mass Spectrometry-Based In Vitro Toxicometabolomics of the Synthetic Cathinones 4-MPD and 4-MEAP in Pooled Human Liver Microsomes

Targeting adipose tissue

Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective

NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells

Epidermal Growth Factor Receptor Pathway Analysis Identifies Amphiregulin as a Key Factor for Cisplatin Resistance of Human Breast Cancer Cells

Y-Box–Binding Protein YB-1 Identifies High-Risk Patients With Primary Breast Cancer Benefiting From Rapidly Cycled Tandem High-Dose Adjuvant Chemotherapy

Allosteric modulation of muscarinic receptor signaling: alcuronium-induced conversion of pilocarpine from an agonist into an antagonist

Pharmacological characterization of the benz[d]indolo[2,3-g]azecine LE300, a novel type of a nanomolar dopamine receptor antagonist

Systemic therapy of Cushing's syndrome

Is sunitinib a Narrow Therapeutic Index Drug? – A systematic review and in vitro toxicology-analysis of Sunitinib vs. Imatinib in cells from different tissues

Resistenzmechanismen von Tumoren gegen Platinkomplexe: Neue Drug Targets und diagnostische Marker

NF546 [4,4′-(Carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-α,α′-diphosphonic Acid) Tetrasodium Salt] Is a Non-Nucleotide P2Y 11 Agonist and Stimulates Release of Interleukin-8 from Human Monocyte-Derived Dendritic Cells

Tyrosine kinase inhibitors becoming generic drugs – risks and chances from a regulatory perspective

Epidermal Growth Factor Receptor Pathway Analysis Identifies Amphiregulin as a Key Factor for Cisplatin Resistance of Human Breast Cancer CellsS

The Y-box Binding Protein YB-1 Is Associated with Progressive Disease and Mediates Survival and Drug Resistance in Multiple Myeloma

Jahrbuch der Heinrich-Heine-Universitat Dusseldorf 2007/2008

Jahrbuch der Heinrich-Heine-Universität Düsseldorf 2007/2008

Der Beitrag der Offizinapotheker zur Optimierung der Arzneimitteltherapiesicherheit - ein Vergleich deutscher, australischer und Schweizer Modelle

Aktive Filter

Suchergebnisse filtern